Publications by authors named "Anton K Emelyanov"

Mutations in the gene, encoding the lysosomal enzyme glucocerebrosidase (GCase), cause Gaucher disease (GD) and are the most common genetic risk factor for Parkinson's disease (PD). Pharmacological chaperones (PCs) are being developed as an alternative treatment approach for GD and PD. To date, NCGC00241607 (NCGC607) is one of the most promising PCs.

View Article and Find Full Text PDF

In this review, we aim to introduce the reader to the technique of electrical impedance spectroscopy (EIS) with a focus on its biological, biomaterials, and medical applications. We explain the theoretical and experimental aspects of the EIS with the details essential for biological studies, i.e.

View Article and Find Full Text PDF

Common variants and risk factors related to familial and sporadic cases of Parkinson's disease (PD) in diverse populations have been identified at numerous genomic loci. In this study, genetic analysis was performed through a screening of LRRK2 G2019S, GBA mutations (L444P, N370S), and common variants (E326K, T369M) in 762 PD patients and in 400 controls. Next-generation sequencing analysis of 22 PD-related genes in 28 early-onset PD cases from North-Western region of Russia was performed.

View Article and Find Full Text PDF
Article Synopsis
  • Parkinson's disease (PD) often has monogenic forms that are rare, making it challenging to identify mutations, particularly in unrelated patients due to the late onset of the disease.
  • The study analyzed 48 unrelated patients with suspected autosomal dominant PD using whole-exome sequencing (WES) and employed various bioinformatics tools to narrow down potential pathogenic variants.
  • Ultimately, the analysis reduced candidate variants from 7082 to 25 significant ones across 23 genes related to PD, highlighting the importance of further experimental verification for the findings.
View Article and Find Full Text PDF